Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer
Cancers · 03.03.2023 · 15 (5) · 1595
DOI: 10.3390/cancers15051595 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.03.2023. Verfasst von Reza Zarinshenas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Management of lung cancer has transformed over the past decade and is no longer considered a singular disease as it now has multiple sub-classifications based on molecular markers. The current treatment paradigm requires a multidisciplinary approach. One of the most important facets of lung cancer outcomes however relies on early detection. Early detection has become crucial, and recent effects have shown success in lung cancer screening programs and early detection. In this narrative review, we evaluate low-dose computed tomography (LDCT) screening and how this screening modality may be underutilized. The barriers to broader implementation of LDCT screening is also explored as well as approaches to address these barriers. Current developments in diagnosis, biomarkers, and molecular testing in early-stage lung cancer are evaluated as well. Improving approaches to screening and early detection can ultimately lead to improved outcomes for patients with lung cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
- Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
ORCID-Profile: Isa Mambetsariev, Jeremy Fricke, Colton Ladbury, Ravi Salgia
Zitieren
APA
Zarinshenas, R., Amini, A., Mambetsariev, I., Abuali, T., Fricke, J., Ladbury, C., & Salgia, R. (2023). Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer. Cancers, 15(5), 1595. https://doi.org/10.3390/cancers15051595
Vancouver
Zarinshenas R, Amini A, Mambetsariev I, Abuali T, Fricke J, Ladbury C, et al. Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer. Cancers. 2023;15(5):1595. doi:10.3390/cancers15051595
BibTeX
@article{Zarinshenas2023,
author = {Zarinshenas, Reza and Amini, Arya and Mambetsariev, Isa and Abuali, Tariq and Fricke, Jeremy and Ladbury, Colton and Salgia, Ravi},
title = {Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {5},
pages = {1595},
doi = {10.3390/cancers15051595}
}
EUVIMED